Actual Medicinal Product (AMP) Vokanamet 50mg/1000mg tablets (A. Menarini Farmaceutica Internazionale SRL)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Original packaging may contain desiccant. Anecdotal reports of use in MCAs for up to 30 days.
- Provenance
-
This recommendation is based on the products Vokanamet 50 mg/1000 mg film-coated tablets (A. Menarini Farmaceutica Internazionale SRL)
- Generic
- Canagliflozin + Metformin
- Formulation
- Canagliflozin 50mg / Metformin 1g tablets
-
Canagliflozin + Metformin
-
Canagliflozin 50mg / Metformin 1g tablets
-
Vokanamet 50mg/1000mg tablets (A. Menarini Farmaceutica Internazionale SRL)
-
-